Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis - PubMed (original) (raw)
. 2006 Sep;54(9):2745-56.
doi: 10.1002/art.22080.
Affiliations
- PMID: 16947383
- DOI: 10.1002/art.22080
Free article
Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis
Adelheid Korb et al. Arthritis Rheum. 2006 Sep.
Free article
Abstract
Objective: Activation of p38 MAPK is a key signaling step in chronic inflammation. Inhibition of p38 MAPK is considered to be a promising future strategy to control inflammatory diseases, but studies of compounds to inhibit this kinase have so far been limited to investigation of their side effects. We undertook the present study to investigate which specific molecule, among 4 different isoforms of p38 MAPK (alpha, beta, gamma, and delta), is predominantly expressed and activated in inflammation. Such knowledge could allow more specific targeting of p38 MAPK in inflammatory disease.
Methods: Studies were performed on inflamed tissue from patients with rheumatoid arthritis, as a prototype of inflammatory disease. The expression and activation of the alpha, beta, gamma, and delta isoforms of p38 MAPK were examined by immunoblotting, immunoprecipitation, and immunohistochemistry.
Results: Immunoblot analysis revealed that alpha and gamma were the predominantly expressed p38 MAPK isoforms, whereas the other 2 isoforms were less frequently present. By immunohistochemistry, the expression of all p38 MAPK isoforms was localized to the synovial lining layer as well as to blood vessels. Colabeling with cell-specific markers revealed that macrophages expressed the alpha and gamma isoforms, synovial fibroblasts the beta and gamma isoforms, and granulocytes the delta isoform, whereas T lymphocytes were rarely positive for any p38 MAPK isoform. Double-labeling with isoform-specific antibody and pan-p38 antibody against the phosphorylated form of p38 MAPK showed activation of the alpha and gamma isoforms. Occasional activation of the beta isoform was also noted in the synovial lining and the endothelium, whereas the delta isoform, although expressed in pericytes around blood vessels, was not phosphorylated. This phosphorylation pattern was confirmed in immunoprecipitation studies in which activated p38 MAPK from synovial tissue extracts was identified as p38 MAPKalpha and -gamma but not p38 MAPKbeta or -delta.
Conclusion: These data show that the alpha and gamma isoforms of p38 MAPK dominate in chronic inflammation. Effective strategies to inhibit p38 MAPK should therefore aim to specifically target either or both of these isoforms.
Similar articles
- Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G. Schett G, et al. Arthritis Rheum. 2000 Nov;43(11):2501-12. doi: 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K. Arthritis Rheum. 2000. PMID: 11083274 - Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKalpha.
Polzer K, Soleiman A, Baum W, Axmann R, Distler J, Redlich K, Kilian A, Krönke G, Schett G, Zwerina J. Polzer K, et al. Ann Rheum Dis. 2008 May;67(5):602-8. doi: 10.1136/ard.2007.077263. Epub 2007 Aug 17. Ann Rheum Dis. 2008. PMID: 17704065 - p38 Mitogen-activated protein kinases on the body surface--a function for p38 delta.
Eckert RL, Efimova T, Balasubramanian S, Crish JF, Bone F, Dashti S. Eckert RL, et al. J Invest Dermatol. 2003 May;120(5):823-8. doi: 10.1046/j.1523-1747.2003.12120.x. J Invest Dermatol. 2003. PMID: 12713588 Review. - p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris.
Mavropoulos A, Orfanidou T, Liaskos C, Smyk DS, Billinis C, Blank M, Rigopoulou EI, Bogdanos DP. Mavropoulos A, et al. Autoimmun Rev. 2013 Mar;12(5):580-90. doi: 10.1016/j.autrev.2012.10.019. Epub 2012 Nov 30. Autoimmun Rev. 2013. PMID: 23207287 Review.
Cited by
- Deletion of p38 MAPK in macrophages ameliorates peritoneal fibrosis and inflammation in peritoneal dialysis.
Ikushima A, Ishimura T, Mori KP, Yamada H, Sugioka S, Ishii A, Toda N, Ohno S, Kato Y, Handa T, Yanagita M, Yokoi H. Ikushima A, et al. Sci Rep. 2024 Sep 11;14(1):21220. doi: 10.1038/s41598-024-71859-5. Sci Rep. 2024. PMID: 39261560 Free PMC article. - Blocking p38γ/δ, a molecular cardiac defibrillator.
Keefe JA, Wehrens XHT. Keefe JA, et al. Nat Cardiovasc Res. 2023 Dec;2(12):1104-1106. doi: 10.1038/s44161-023-00363-2. Nat Cardiovasc Res. 2023. PMID: 39196142 No abstract available. - Unveiling the Nexus: Cellular Metabolomics Unravels the Impact of Estrogen on Nicotinamide Metabolism in Mitigating Rheumatoid Arthritis Pathogenesis.
Malik S, Chakraborty D, Agnihotri P, Kumar V, Biswas S. Malik S, et al. Metabolites. 2024 Apr 11;14(4):214. doi: 10.3390/metabo14040214. Metabolites. 2024. PMID: 38668342 Free PMC article. - Rheumatoid arthritis-recent advances in pathogenesis and the anti-inflammatory effect of plant-derived COX inhibitors.
Bashir U, Singh G, Bhatia A. Bashir U, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5363-5385. doi: 10.1007/s00210-024-02982-3. Epub 2024 Feb 15. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38358467 Review. - A Promising Drug Candidate as Potent Therapeutic Approach for Neuroinflammation and Its In Silico Justification of Chalcone Congeners: a Comprehensive Review.
Karati D, Mukherjee S, Roy S. Karati D, et al. Mol Neurobiol. 2024 Apr;61(4):1873-1891. doi: 10.1007/s12035-023-03632-0. Epub 2023 Oct 6. Mol Neurobiol. 2024. PMID: 37801205 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical